Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy.

Abstract excerpt

Rhabdoid tumors are rare but highly aggressive tumors with a predilection for infants and young children. The majority of these tumors harbor biallelic mutations in SMARCB1/INI1/hSNF5. Rather rare cases with mutations in other SWI/SNF core members such as BRG1 are on record. Rhabdoid tumors have only recently been registered and treated according to specifically designed treatment recommendations and in the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chromosomal Proteins, Non-Histone
• Share to Clinical Trials as Topic